- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Deep Vein Thrombosis in New Zealand
Total 466 results
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicUnited States, Bulgaria, Italy, Peru, Russian Federation, Canada, France, Germany, Hong Kong, Spain, Sweden, United Kingdom, Hungary, Poland, Ukraine, Czech Republic, India, Australia, Tunisia, Puerto Rico, Pakistan
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingAtypical Hemolytic Uremic SyndromeUnited States, Belgium, China, France, Spain, Canada, South Africa, Japan, Brazil, Italy, Poland, India, Hungary, Mexico, Israel
-
BayerCompletedHemodialysis | End-stage Renal Disease | Hemodiafiltration | Prevention of Thromboembolic EventsSpain, Greece, Belgium, Russian Federation, Netherlands, Turkey, Japan, Australia, Austria, Bulgaria, Italy, Ukraine, Czechia, Israel, United States, Hungary, Lithuania, Poland, Portugal
-
Sobi, Inc.Active, not recruitingImmune ThrombocytopeniaUnited States, France, Germany, Hungary, Poland, Russian Federation, Turkey, Ukraine, United Kingdom
-
Novartis PharmaceuticalsRecruitingPrimary Immune Thrombocytopenia (ITP)China, United States, Spain, Singapore, Austria, Germany, Belgium, Italy, Japan, Czechia, Hong Kong, Hungary, Malaysia, Argentina, Bulgaria, Turkey, Vietnam, Australia, Thailand, Mexico, United Kingdom, France, Romania, Norway, India
-
AmgenCompletedIdiopathic Thrombocytopenic PurpuraItaly, United States, Germany, Czechia, United Kingdom, Australia, Spain, Poland, France
-
Novartis PharmaceuticalsRecruitingPrimary Immune Thrombocytopenia (ITP)Spain, Italy, France, Germany, China, Korea, Republic of, Czechia, Turkey, Malaysia, United States, Argentina, Australia, United Kingdom, Poland
-
Alexion PharmaceuticalsTerminatedAtypical Hemolytic Uremic SyndromeFrance, Canada, United States, Belgium, Italy, United Kingdom, Netherlands, Australia, Austria, Germany, Sweden, Switzerland
-
Alexion Pharmaceuticals, Inc.CompletedAtypical Hemolytic Uremic Syndrome (aHUS)Italy, United States, Korea, Republic of, Spain, Germany, Belgium, United Kingdom
-
Novartis PharmaceuticalsCompletedImmune Thrombocytopenic Purpura (ITP)Spain, Italy, Greece, Switzerland, United Kingdom, France, Turkey, Russian Federation, Brazil, Austria, Mexico, Oman, Chile, Japan, United States
-
Principia Biopharma, a Sanofi CompanyRecruitingImmune ThrombocytopeniaUnited States, China, Argentina, Australia, Brazil, Canada, France, Hungary, Israel, Korea, Republic of, Mexico, Russian Federation, Singapore, Spain, Thailand, United Kingdom, Austria, Chile, Germany, Italy, Japan, Netherlands, Norway and more
-
Baxalta now part of ShireCompletedPrimary Immunodeficiency Diseases (PID) | Immune Thrombocytopenic Purpura (ITP) | Kawasaki SyndromeUnited States
-
AlexionSyneos HealthRecruitingAtypical Hemolytic-Uremic SyndromeFrance, Germany, Israel, Italy, United Kingdom, Canada, United States, Australia, Belgium, Denmark, Korea, Republic of, Poland, Russian Federation, Spain, Taiwan
-
Novartis PharmaceuticalsRecruitingAtypical Hemolytic Uremic SyndromeChina, Korea, Republic of, Austria, Taiwan, Greece, Czechia, United States, Japan, Brazil, United Kingdom, India, Slovakia, Slovenia
-
GlaxoSmithKlineCompletedIdiopathic Thrombocytopenic PurpuraThailand, Israel, Poland, Russian Federation, Spain, Germany, United Kingdom, Taiwan, Hong Kong, Czech Republic, Italy, United States, Argentina
-
Novartis PharmaceuticalsRecruitingPrimary Immune ThrombocytopeniaUnited States, China, Germany, Spain, Singapore, Japan, Taiwan, Belgium, Italy, Czechia, Hungary, Malaysia, Korea, Republic of, Turkey, Argentina, Thailand, India, United Kingdom, France, Australia, Romania, Austria, Norway, Netherlands, Philippin...